Servier Symphogen A/S
Advancing innovative antibody therapeutics to improve cancer patient outcomes globally.
Oversikt
- 163
- Ansatte
- Ukjent
- Omsetning
- 2000
- Grunnlagt
Beskrivelse
Servier Symphogen is the dedicated Antibody Center of Excellence within the global Servier Group, specializing in the discovery and early development of innovative antibody therapeutics. Founded in 2000 and acquired by Servier in 2020, the company focuses primarily on advancing treatments for oncolo...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- A/S
- MVA-nummer
- DK10013267
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Y-mAbs Therapeutics A/S
43 ansatteDeveloping innovative radioimmunotherapy and antibody-based treatments for challenging cancers.
SERVIER DANMARK A/S
5 ansatteA global pharmaceutical company focused on cardiovascular and oncology research.
GENMAB A/S
562 ansattePioneering biotechnology company developing innovative antibody therapeutics for serious diseases.
BioInvent International Aktiebolag
100–199 ansatteClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB
13 ansatteInternational pharmaceutical group focused on innovative respiratory and rare diseases.
Spørsmål om Servier Symphogen A/S
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo